Swedish Orphan Biovitrum AB/  SE0000872095  /

OMX Nordic Equities
11/21/2019  5:29:51 PM Chg. +0.55 Volume Bid5:29:51 PM Ask5:29:51 PM Market Capitalization Dividend Y. P/E Ratio
159.55SEK +0.35% 680,268
Turnover: 102.54 mill.
158.95Bid Size: 304 159.15Ask Size: 479 43 bill.SEK 0.00% 17.79

Fundamentals

  FY 2018 Growth (1Y)
Per Share  
Earnings per Share: 8.97 SEK 110.07%
EPS Diluted: 8.93 SEK 110.12%
Revenues per Share: 33.91 SEK 40.10%
Book Value per Share: 33.54 SEK 34.66%
Cash Flow per Share: 7.76 SEK 56.53%
Dividend per Share: 0.00 SEK -
Total in mill.  
Revenues: 9,138.90 SEK 40.37%
Net Income: 2,417.80 SEK 110.50%
Operating Cash Flow: 2,090.30 SEK -
Cash and Cash Equivalents: 2,998.70 SEK -

Valuation Ratios

  Current Latest FY*
P/E Ratio: 17.79 21.52
P/S Ratio: 4.71 5.69
P/BV ratio: 4.76 5.75
P/CF Ratio: 20.57 24.89
PEG: 0.16 0.20
Earnings Yield: 5.62% 4.65%
Dividend Yield: 0.00% 0.00%
Market Capitalization  
Market Capitalization: 43 bill. SEK 52.02 bill. SEK
Free Float Market Cap.: 18.33 bill. SEK 22.17 bill. SEK
Market Cap. / Employee: 47.67 mill. SEK 57.67 mill. SEK
Shares Outstanding: 273.32 mill.  
 

Profitability

Gross Profit Margin: 73.57%
EBIT Margin: 34.16%
Net Profit Margin: 26.46%
Return on Equity: 26.75%
Return on Assets: 14.07%

Financial Strength

Liquidity I / Cash Ratio: 43.14%
Liquidity II / Quick Ratio: 67.10%
Liquidity III / Current Ratio: 94.98%
Debt / Equity Ratio: 90.08%
Dynam. Debt / Equity Ratio: 389.57%

Efficiency

Employees: 902
Personal Expenses / Employee: 1,210,643.02 SEK
Revenues / Employee: 10,131,818.18 SEK
Net Income / Employee: 2,680,487.80 SEK
Total Assets / Employee: 19,050,110.86 SEK
 
* Fiscal Year End: 12/31/2018
Accounting Standard: IFRS
Currency: SEK